Although the following needs a couple of updates (Striate+ has been approved in Canada and possibly Top-line results from Remplir™ US market authorisation study expected in Q4 CY24), I'm happy to see the latest presentation. It includes new information that should assist in aligning investor's expectations with the Company's:
https://www.bioshares.com.au/file/78/view/OCC.pdf
Although the following needs a couple of updates (Striate+ has...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.115(10.5%) |
Mkt cap ! $295.5M | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.22 | $1.14 | $1.024M | 867.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2480 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 5000 | 2 |
View Market Depth
| Last trade - 11.14am 16/09/2025 (20 minute delay) ? |
| OCC (ASX) Chart |